mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |